Skip to main content

Table 6 Annual costs (2008 Euros) per FM patient, and by FM severity

From: Societal and individual burden of illness among fibromyalgia patients in France: Association between disease severity and OMERACT core domains

Resource Utilization Cost Total
(n = 88)
Mild
(n = 17)
Moderate
(n = 33)
Severe
(n = 38)
 
  Mean (SD) Median Mean (SD) Median Mean (SD) Median Mean (SD) Median P -value a
Direct Medical Costs to Payerb          
Physician Visits 259 (163) 264 271 (118) 264 219 (112) 264 288 (208) 264  
Diagnostic Tests 14 (38) 0 26 (61) 0 7 (20) 0 13 (37) 0  
Prescription Medications 245 (345) 107 153 (207) 43 213 (312) 102 314 (409) 144  
Hospitalizations 104 (972) 0 0 (0) 0 276 (1,587) 0 0 (0) 0  
Direct Medical Costs to Patientc 186 (425) 0 113 (256) 0 233 (448) 0 179 (467) 0  
Total Direct Medical Costs to Society 808 (1,215) 540 564 (440) 528 949 (1,842) 504 794 (636) 595 0.434
Direct Non-Medical Cost to Patientc        
Professional services for ADL 103 (501) 0 93 (274) 0 108 (428) 0 103 (633) 0  
Total Indirect Costs to Societyc         
Lost productivity 6,990 (14,561) 0 4,816 (12,433) 0 5,576 (12,736) 0 9,190 (16,808) 0  
Total Direct and Indirect Costs to Society 7,900 (14,868) 616 5,473 (12,852) 610 6,633 (13,498) 528 10,087 (16,785) 890 0.185
  1. Extrapolated from 4-week patient-reported data and 3-month clinical case report form data
  2. aKruskal-Wallis test.
  3. bBased on unit cost and data reported in Clinical case report form.
  4. cBased on patient-reported data from study.
  5. ADL: activities of daily living